Pfizer Biontech
India  /  Published 27.01.22

Omicron booster for better immunity: Study

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...
By GS Mudur in New Delhi

World  /  Published 22.01.22

Boosters key to Covid fight

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...
By Apoorva Mandavilli in New York

World  /  Published 22.10.21

Pfizer booster jab

Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their Covid-19 vaccine against the virus, including the Delta var...
By Reuters in Berlin

India  /  Published 21.09.21

India won't buy Pfizer, Moderna jabs: Report

India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccin...
By Reuters in New Delhi

India  /  Published 20.09.21

Pfizer-BioNTech vaccine safe for kids of 5-11 yrs

Global pharma major Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralizing antibody response in children aged five to 11 years,...
By Our bureau and PTI in New Delhi


World  /  Published 18.08.21

Jab effective against Delta variant

The Delta variant of the SARS-CoV-2 virus, that causes Covid-19, is unable to evade the antibodies generated by vaccination, according to a lab study. The findings, published in the journal Immunity,...
By Our Bureau, PTI in Washington

World  /  Published 24.07.21

Pfizer: longer gap boosts immunity

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University ...
By H S Rao in London

World  /  Published 14.07.21

More Pfizer booster-shot data needed

Representatives of Pfizer met privately with senior US scientists and regulators on Monday to press their case for swift authorisation of coronavirus booster vaccines, amid growing public confusion ab...
By Sheryl Gay Stolberg, Sharon LaFraniere in Washington

World  /  Published 08.07.21

Jabs work against Delta, say studies

As the Delta variant sweeps the world, researchers are tracking how well vaccines protect against it — and getting different answers. In Britain, researchers reported in May that two doses of t...
By New York Times News Service in New York

World  /  Published 07.07.21

Moderna takers 91% less likely to have Covid

People who receive Covid-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severit...
By Our Bureau, PTI in Washington


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.